First outbreak of multidrug-resistant Klebsiella pneumoniae carrying blaVIM-1 and blaSHV-5 in a French university hospital
Open Access
- 10 November 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 57 (1) , 142-145
- https://doi.org/10.1093/jac/dki389
Abstract
Objectives: We studied eight imipenem-resistant isolates of Klebsiella pneumoniae involved in an outbreak in a French teaching hospital. Methods: The eight isolates were recovered from clinical specimens or rectal swabs. Antibiotic susceptibilities were determined using standard agar diffusion and dilution methods including synergy tests. PFGE was used to study the relatedness of isolates. Genes encoding β-lactamases were characterized by transfer assays, specific amplification and cloning. Results: The eight isolates were closely related by PFGE analysis and highly related to a K. pneumoniae strain from Greece. They were highly resistant to β-lactams, including aztreonam and imipenem (MIC ≥32 mg/L), and were positive by the imipenem-EDTA disc synergy test. Isolates were also resistant to aminoglycosides, newer quinolones and sulfamethoxazole, and showed an intermediate level of resistance to tetracycline. VIM-1 and SHV-5 β-lactamases were revealed in all isolates by PCR. The analysis of plasmid contents of Escherichia coli DH10B electroporants expressing the VIM-1 β-lactamase or the SHV-5 β-lactamase confirmed that the two enzymes were coded by two different plasmids. The blaVIM-1 gene was part of a class 1 integron that also included aac6, dhfrI and aadA genes and was similar to those reported from strains isolated in Greece. Conclusions: This study confirms the potential risk of spread of multiresistant bacteria with international transfer of patients.Keywords
This publication has 16 references indexed in Scilit:
- Metallo-β-Lactamases: the Quiet before the Storm?Clinical Microbiology Reviews, 2005
- Outbreak of multi-resistant Klebsiella oxytoca involving strains with extended-spectrum β-lactamases and strains with extended-spectrum activity of the chromosomal β-lactamaseJournal of Antimicrobial Chemotherapy, 2004
- First identification of an Escherichia coli clinical isolate producing both metalloβ-lactamase VIM-2 and extended-spectrum β-lactamase IBC-1Clinical Microbiology & Infection, 2004
- Spread of blaVIM-1-producing e. coli in a university hospital in Greece. Genetic analysis of the integron carrying the blaVIM-1 metallo-β-lactamase geneDiagnostic Microbiology and Infectious Disease, 2004
- Emergence in Klebsiella pneumoniae and Enterobacter cloacae Clinical Isolates of the VIM-4 Metallo-β-Lactamase Encoded by a Conjugative PlasmidAntimicrobial Agents and Chemotherapy, 2004
- VIM-1 Metallo-β-Lactamase-Producing Klebsiella pneumoniae Strains in Greek HospitalsJournal of Clinical Microbiology, 2003
- Escherichia coli with a Self-Transferable, Multiresistant Plasmid Coding for Metallo-β-Lactamase VIM-1Antimicrobial Agents and Chemotherapy, 2003
- Cloning and Characterization of bla VIM , a New Integron-Borne Metallo-β-Lactamase Gene from a Pseudomonas aeruginosa Clinical IsolateAntimicrobial Agents and Chemotherapy, 1999
- Clinical and Bacteriologic Epidemiology of Extended‐Spectrum s‐Lactamase –Producing Strains ofKlebsiella pneumoniaein a Medical Intensive Care UnitClinical Infectious Diseases, 1998
- beta-Lactamases in laboratory and clinical resistanceClinical Microbiology Reviews, 1995